They Just Don't Get...
Health Care: Drugs
Indevus Pharmaceuticals Incorporated (IDEV: NASDAQ)
$5.60 -0.40 | -6.67%
03/23/09 - 04:00 PM ET
824.75K / 1.83M
Vol / Avg. Vol:6.03 / 6.00
Open / Prev. Close:5.57 - 6.10
Today's Range:1.19 - 6.15
52 Wk Range:78.34%
Performance YTD:TheStreet Rating:
Portfolios with IDEV
- Portfolio NameUser Type
- UserRAPTOR LAST 2
- UserRGLD1
- UserStephenAttemptAtHealthyReti...
- UserRobert Kronenberg Portfolio 1
- Userspurusone
- ProFranklin Biotechnology Disc...
- Userjwil258on Portfolio 1
- Userabraswell Portfolio 1
- Usermchamo Portfolio 1
- Userrickey322 Portfolio 1
Latest IDEV Headlines from TheStreet
- Endo 3Q Profit Falls On Indevus Buyout Costs 10.29.09 | 08:10 am
- FDA Extends Review Of Endo Drug By 3 Months 09.02.09 | 04:09 pm
- Endo Says FDA Accepts Application For Nebido 03.12.09 | 12:03 pm
- Endo Pharma to Buy Indevus for $370M 01.05.09 | 05:01 pm
- Health Winners & Losers: Indevus 09.26.08 | 05:09 pm
- Indevus Soars on FDA, Partnership News (Update) 09.26.08 | 12:09 pm
- Indevus Soars on Improved FDA Timeline 09.26.08 | 10:09 am
- Monday's Winners & Losers: Sirius 06.30.08 | 04:06 pm
- Health Winners & Losers: Myriad Genetics 06.30.08 | 04:06 pm
- Feuerstein's Biotech-Stock Mailbag: Panacos 06.20.08 | 11:06 am
Press Releases for IDEV
Partner Headlines for IDEV
